Focus

Leqembi

Health News
Health News

Alzheimer’s Drug Leqembi Has Full FDA Approval Now and That Means Medicare Will Pay for It

Alzheimer’s Drug Leqembi Has Full FDA Approval Now and That Means Medicare Will Pay for It
|
Dementia & Alzheimer's
Dementia & Alzheimer's

Alzheimer’s Drug Leqembi Gains FDA Panel’s Support for Full Approval

Alzheimer’s Drug Leqembi Gains FDA Panel’s Support for Full Approval
|
Health News
Health News

VHA to Cover Eisai, Biogen’s Alzheimer’s Drug for Eligible Veterans

VHA to Cover Eisai, Biogen’s Alzheimer’s Drug for Eligible Veterans
|
Alzheimer's Disease
Alzheimer's Disease

Lecanemab May Reverse Alzheimer’s Disease, But 3 Deaths Raise Questions

Lecanemab May Reverse Alzheimer’s Disease, But 3 Deaths Raise Questions
|
Health News
Health News

Alzheimer’s Drug Leqembi Has Full FDA Approval Now and That Means Medicare Will Pay for It

Alzheimer’s Drug Leqembi Has Full FDA Approval Now and That Means Medicare Will Pay for It
|
Dementia & Alzheimer's
Dementia & Alzheimer's

Alzheimer’s Drug Leqembi Gains FDA Panel’s Support for Full Approval

Alzheimer’s Drug Leqembi Gains FDA Panel’s Support for Full Approval
|
Health News
Health News

VHA to Cover Eisai, Biogen’s Alzheimer’s Drug for Eligible Veterans

VHA to Cover Eisai, Biogen’s Alzheimer’s Drug for Eligible Veterans
|
Alzheimer's Disease
Alzheimer's Disease

Lecanemab May Reverse Alzheimer’s Disease, But 3 Deaths Raise Questions

Lecanemab May Reverse Alzheimer’s Disease, But 3 Deaths Raise Questions
|